HIGH QUALITY SCIENTIFIC CONTENT,  ONLINE OPEN ACCESS,  GLOBAL SCIENTIFIC AUDIENCE,  COST EFFECTIVE, ANY ONE CAN DOWNLOAD REPRINTS 
Spreading knowledge

Google Scholar

Google Scholar

Archives

Back 

ROLE OF NANOTECHNOLOGICAL ADVANCEMENTS IN CANCER MANAGEMENT. Rekha Rao, Kapil Singla, Sanju Nanda, Sarita khatkar

ROLE OF NANOTECHNOLOGICAL ADVANCEMENTS IN CANCER MANAGEMENT.

Rekha Rao, Kapil Singla, Sanju Nanda, Sarita khatkar

International Journal of Natural Product Science 2012: Spl Issue 1:65.

Abstract (RBIP-65)

Cancer stands first among killing diseases worldwide. It is the state of uncontrolled cell division governed by the damaged genes which can be detected and treated by identifying the responsible cells. Treatment can be done by repairing the damaged genes or by stopping the blood supply to that particular region and sometimes, destroying the whole area. Conventional chemotherapeutic agents are distributed nonspecifically throughout the body affecting both cancerous as well as healthy cells. Non-specific delivery may lead to various types of problems, most significantly the resistance to the therapy. Nowadays, the new site specific delivery systems have been explored that act only to affected cells, without affecting the healthy ones. Site specific drug delivery systems are the increasing needs of healthcare evokes and may act as support for the existing cancer treatment therapies. These systems include the micro and nano sized systems (nano- capsules, emulsions, liposomes, niosomes, solid lipid nanoparticles etc.) provide better platform for the cancer treatment. Recent amendments in cancer nanotechnology provide more opportunities for controlled and site specific delivery. Hence, nanotechnology application may benefit cancer management.
Attachments:
Time to create page: 0.11 seconds


Copyright © All rights reserved Science Instinct Publications sciipub.com